Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2679CTIDB
  • |
  • Pages: 80
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015" provides data on the Ileus (Intestinal Obstruction) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ileus (Intestinal Obstruction) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ileus (Intestinal Obstruction) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Ileus (Intestinal Obstruction) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Ileus (Intestinal Obstruction) 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Ileus (Intestinal Obstruction) Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Tsumura & co. 31

Clinical Trial Overview of Tsumura & co. 31

Valeant Pharmaceuticals International, Inc. 33

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 33

Merck & Co., Inc. 34

Clinical Trial Overview of Merck & Co., Inc. 34

Norgine B.V. 35

Clinical Trial Overview of Norgine B.V. 35

Ipsen S.A. 36

Clinical Trial Overview of Ipsen S.A. 36

GlaxoSmithKline plc 37

Clinical Trial Overview of GlaxoSmithKline plc 37

Pfizer Inc. 38

Clinical Trial Overview of Pfizer Inc. 38

Ocera Therapeutics, Inc. 39

Clinical Trial Overview of Ocera Therapeutics, Inc. 39

Cato Research Ltd. 40

Clinical Trial Overview of Cato Research Ltd. 40

Botanic Century 41

Clinical Trial Overview of Botanic Century 41

Clinical Trial Overview of Top Institutes / Government 42

Japanese Foundation for Cancer Research 42

Clinical Trial Overview of Japanese Foundation for Cancer Research 42

Chiang Mai University 43

Clinical Trial Overview of Chiang Mai University 43

Nanjing PLA General Hospital 44

Clinical Trial Overview of Nanjing PLA General Hospital 44

Queen's University 45

Clinical Trial Overview of Queen's University 45

University Medicine Greifswald 46

Clinical Trial Overview of University Medicine Greifswald 46

Wakayama Medical University 47

Clinical Trial Overview of Wakayama Medical University 47

Academic Medical Center 48

Clinical Trial Overview of Academic Medical Center 48

Atrium Medical Center 49

Clinical Trial Overview of Atrium Medical Center 49

Azienda Ospedaliera Universitaria Policlinico catania 50

Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 50

Baqiyatallah Medical Sciences University 51

Clinical Trial Overview of Baqiyatallah Medical Sciences University 51

Five Key Clinical Profiles 52

Appendix 78

Abbreviations 78

Definitions 78

Research Methodology 79

Secondary Research 79

About GlobalData 80

Contact Us 80

Disclaimer 80

Source 80

List of Figures

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 79

List of Tables

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Ileus (Intestinal Obstruction) Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tsumura & co., 2015* 31

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 33

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 34

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine B.V., 2015* 35

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 36

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 39

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015* 40

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Botanic Century, 2015* 41

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Foundation for Cancer Research, 2015* 42

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015* 43

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing PLA General Hospital, 2015* 44

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 45

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medicine Greifswald, 2015* 46

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wakayama Medical University, 2015* 47

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 48

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Atrium Medical Center, 2015* 49

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2015* 50

Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2015* 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Tsumura & co.

Valeant Pharmaceuticals International, Inc.

Merck & Co., Inc.

Norgine B.V.

Ipsen S.A.

GlaxoSmithKline plc

Pfizer Inc.

Ocera Therapeutics, Inc.

Cato Research Ltd.

Botanic Century

Ileus (Intestinal Obstruction) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ileus (Intestinal Obstruction) , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160900
Site License
USD 5000 INR 321800
Corporate User License
USD 7500 INR 482700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com